This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 52386507
Submitted by lobbyist on: December 3, 2019 10:29:56 AM
Accepted by Registrar on: December 3, 2019 10:58:12 AM
Lobbyist Information
| Williamson, Matt |
| 740 - 730 View Street | |
|
Victoria, BC, V8W 3Y7
|
250-858-7895 |
| Canada |
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbyist Firm Information
| Global Public Affairs |
| 740 - 730 View Street | |
|
Victoria, BC, V8W 3Y7
|
250-858-7895 |
| Canada |
Client Information
| Innovative Medicines Canada |
| Innovative Medicines Canada (IMC) represents Canada's pharmaceutical industry, working to discover, develop and deliver innovative medicines and vaccines. IMC's membership consists of over 50 companies, from established organizations to fledgling startups. |
| 1220 - 55 rue Metcalfe St. | |
|
Ottawa, ON, K1P 6L5
|
403-984-3244 |
| Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
| November 26, 2019 | |
| May 31, 2020 |
There are no other individuals engaged to lobby on this undertaking.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
To engage the B.C. government on drug policy development, healthcare sustainability, job creation and the the growth of B.C.'s knowledge-based economy.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Government Communications and Public Engagement | December 3, 2019 | |
| Public Agency | Health | December 3, 2019 | |
| Public Agency | Jobs, Trade and Technology | December 3, 2019 |